Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005558,
umls-concept:C0030247,
umls-concept:C0030705,
umls-concept:C0035820,
umls-concept:C0036576,
umls-concept:C0041618,
umls-concept:C0138741,
umls-concept:C0178587,
umls-concept:C0194804,
umls-concept:C0205344,
umls-concept:C0600139,
umls-concept:C0750491,
umls-concept:C0750572,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1707455
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
1993-5-25
|
pubmed:abstractText |
We retrospectively reviewed the findings relative to 95 patients with known prostate specific antigen (PSA) values who had undergone digital rectal examination, transrectal US and US-guided biopsy for suspected prostate carcinoma. Histology (48 adenocarcinomas, 26 BPHs, 12 inflammations and 9 negatives) was compared with results from rectal examination, prostate US, PSA values and "density" (PSA/prostatic volume, as measured with US). PSA values < 4 ng/ml exhibited 90% negative predictive value and PSA > 10 ng/ml 70.8% positive predictive value. In the intermediate range (4-9.9 ng/ml) the positive predictive value of PSA was 44.4% and its negative predictive value was 55.5%. PSA density did not affect predictive values in the two groups with PSA < 4 and > 10 ng/ml, while in the intermediate 4-9.9 ng/ml group, positive predictive value raised to 62.5% and negative predictive value to 81.8%, thus increasing the specificity of PSA values and US findings. Our results suggest that PSA should be the examination of choice in the patients with prostatic disease. Follow-up with PSA dosage after one year may be suggested when PSA < 4 ng/ml. PSA density can be helpful in patients with PSA values ranging 4-9.9 ng/ml; biopsy should be performed when the index > 0.15, while follow-up at 6 months should be performed when the index < 0.15. PSA values > 10 ng/ml require further evaluation with rectal examinations, prostate US and US-guided biopsy. Random biopsies are suggested when PSA values are > 20 ng/ml.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-8362
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
84-9
|
pubmed:dateRevised |
2008-10-21
|
pubmed:meshHeading |
pubmed-meshheading:7683136-Adenocarcinoma,
pubmed-meshheading:7683136-Aged,
pubmed-meshheading:7683136-Aged, 80 and over,
pubmed-meshheading:7683136-Biopsy, Needle,
pubmed-meshheading:7683136-Evaluation Studies as Topic,
pubmed-meshheading:7683136-Humans,
pubmed-meshheading:7683136-Male,
pubmed-meshheading:7683136-Middle Aged,
pubmed-meshheading:7683136-Palpation,
pubmed-meshheading:7683136-Prostate,
pubmed-meshheading:7683136-Prostate-Specific Antigen,
pubmed-meshheading:7683136-Prostatic Hyperplasia,
pubmed-meshheading:7683136-Prostatic Neoplasms,
pubmed-meshheading:7683136-Rectum,
pubmed-meshheading:7683136-Retrospective Studies,
pubmed-meshheading:7683136-Sensitivity and Specificity
|
pubmed:articleTitle |
[The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
|
pubmed:affiliation |
Istituto di Radiologia 2, Ospedale Civile di Udine.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|